Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
RESEARCH TOOLSreports
Holding CNTB?
Track your performance easily
Connect Biopharma Holdings (CNTB) Ownership Overview
11.70%
Insiders
0.05% Mutual Funds
4.85% Other Institutional Investors
83.40% Public Companies and
Individual Investors
The ownership structure of Connect Biopharma Holdings (CNTB) stock is a mix of institutional, retail, and individual investors. , 11.70% is owned by Insiders, and 83.40% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,487,545 | Insider | 11.70% | 6,344,819 | |
| 3,062,871 | Institution | 5.54% | 2,995,488 | |
| 27,961 | Institution | 0.05% | 27,346 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 27,961 | Institution | 0.05% | 27,346 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Connect Biopharma Holdings (CNTB)?
According to the latest TipRanks data, approximately 4.85% of the company's stock is held by institutional investors, 11.70% is held by insiders, and 83.40% is held by retail investors.
What percentage of Connect Biopharma Holdings (CNTB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.85% of Connect Biopharma Holdings (CNTB) stock is held by institutional investors.
What percentage of Connect Biopharma Holdings (CNTB) stock is held by retail investors?
According to the latest TipRanks data, approximately 83.40% of Connect Biopharma Holdings (CNTB) stock is held by retail investors.
Who owns the most shares of Connect Biopharma Holdings (CNTB)?
Wei Zheng owns the most shares of Connect Biopharma Holdings (CNTB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.